J&J's $30B takeover keeps cash overseas

Johnson & Johnson is spending $30 billion of its overseas cash pile on a Swiss biopharmaceutical company, Actelion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.